Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 10, 2026
TickeronGET DAILY SIGNALS
Sally Beauty Holdings (SBH): Evaluating the +28% Upside to a $25 Target

Sally Beauty Holdings (SBH): Evaluating the +28% Upside to a $25 Target

Key Takeaways

  • The $25 central target is a valuation-based objective drawn from public DCF analysis that places intrinsic value in the mid-$20s; it is not an analyst price-target consensus.
  • The latest verified price of roughly $19.49 sits near the 52-week high of about $19.60, meaning a move to $25 would require roughly 28% upside — a substantial move.
  • The arithmetic mean of five verifiable analyst targets is about $17.40, with a wide range from $13 (Morgan Stanley) to $20 (Canaccord Genuity); only one target sits above the current price.
  • Supporting factors include a fiscal Q4 2026 earnings beat, initial fiscal 2027 adjusted EPS guidance of $2.20–$2.30, strong free cash flow, and an aggressive share-repurchase program.
  • Key risks are low-single-digit sales growth, margin pressure in the care category and Beauty Systems Group, and a persistently low valuation multiple.
  • Readers can explore Major News, Today's Price Move, a detailed Forecast, and upcoming Earnings on additional pages for deeper context on this ticker.
  • For automated market insight, consider exploring Trending AI Robots, which surface changing technical and fundamental conditions across thousands of assets.

Why Conventional Analyst Targets Fall Short

Because SBH has rallied sharply, the conventional analyst framework breaks down. Five verifiable, current analyst price targets were reviewed: Canaccord Genuity (Buy, $20, September 2026), TD Cowen (Buy, $19, August 2026), Raymond James (Buy, $19, January 2026), Jefferies (Hold, $16, January 2026), and Morgan Stanley (Sell, $13, August 2026). Their arithmetic mean is about $17.40, spanning a wide $13-to-$20 range — a spread that reflects genuine disagreement about how much this low-multiple, low-growth business is worth. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Crucially, that mean sits below the current price, and only Canaccord Genuity's $20 target remains above it. With fewer than two credible targets above the market, the analyst consensus cannot supply a meaningful upside objective. The $25 figure used here is therefore a fallback: it reflects DCF-based fair-value estimates in public equity commentary that have placed intrinsic value near $25, resting on SBH's cash-flow generation and capital-return discipline rather than on any single analyst's forecast.

Current Price Position and Path to the Target

At a recent close of $19.49, reaching $25 would require a gain of roughly 28% — a substantial move for a stock already trading near its 52-week high. The path would likely depend less on a valuation re-rating alone and more on sustained earnings growth. Fiscal Q4 2026 (ended September 30, 2026) results reported in early November showed net sales up 0.6% to $953 million, comparable sales up 0.9%, and adjusted diluted EPS up 13% to $0.62, beating expectations. Management's initial fiscal 2027 guidance calls for adjusted EPS of $2.20–$2.30, implying double-digit earnings growth on roughly 1%–2% comparable-sales growth, with about $200 million of expected free cash flow.

Factors That Could Support Higher Prices

Several verified factors could support a higher price. The Sally Beauty Supply segment posted 2.0% comparable-sales growth in the quarter, with U.S. and Canada comps up 3.8% and color sales up 9%. The company's "Sally Ignited" store format is comping well above the fleet average, and management plans roughly 100 additional locations in fiscal 2027 as it moves from pilot to scale. Strong free cash flow, a reduced net-debt leverage ratio of 1.4x, and $113 million of share repurchases in fiscal 2026 (which shrink the share count and lift per-share earnings) all provide a foundation for EPS growth even with modest top-line gains.

Obstacles That Could Limit Upside

The obstacles are equally real. Revenue growth remains low-single-digit, the care category declined 7% in the quarter, and the professional Beauty Systems Group continues to lag with negative comps. Gross margin slipped 30 basis points in Q4 as new, lower-margin categories mix in, and analysts have warned that the prior year's cost-savings tailwind is fading. A low valuation multiple can persist for years when a company is perceived as structurally low-growth, and the stock's proximity to its 52-week high means it faces little technical headroom and the psychological resistance of the round $20 level.

Technical Levels Worth Monitoring

SBH trades right at its 52-week high near $19.60, a level that now serves as immediate resistance, with the round $20 mark just above it. A decisive close above $20 would mark a fresh multi-year high. On the downside, the prior breakout zone around $18 and the October consolidation area near $16.50–$17.00 are the first meaningful support levels investors are watching. From what I see, the technical setup warrants close attention here.

Time Horizon and Items to Track

The $25 objective is a valuation-based estimate without a fixed date, though most analyst targets reviewed here reflect a roughly 12-month research horizon. Investors should monitor execution of the Sally Ignited rollout, whether Beauty Systems Group returns to positive comps as management projects, progress on the fiscal 2027 adjusted EPS target of $2.20–$2.30, and any analyst revisions following the quarterly report. Macroeconomic variables — consumer spending on discretionary beauty categories, promotional intensity, and interest rates — will also shape the path. I'm watching this closely for signs of sustained momentum.

Putting It All Together

Can SBH reach $25? The target is a substantial 28% above the latest price and rests on a valuation argument rather than analyst consensus — whose mean of roughly $17.40 actually sits below the market. The bull case leans on accelerating same-store sales in the core Sally segment, double-digit projected EPS growth, and heavy buybacks; the bear case points to sluggish top-line growth, segment-level softness, and fading margin tailwinds. The $13-to-$20 analyst range underscores how divided the Street remains. No outcome is guaranteed, and the next test will be whether fiscal 2027 guidance converts into sustained earnings momentum and a break above the $20 resistance zone.

Using Tickeron AI Tools in My Process

In my research process, I often turn to Tickeron’s AI Daily Buy/Sell Signals to get an additional layer of insight on stocks like SBH. The tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. It helps traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening allows. For investors following a fast-moving name like this, such signals can add a data-driven layer to fundamental research without replacing it.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SBH

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


SBH's Stochastic Oscillator remains in overbought zone for 12 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SBH moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In 17 of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SBH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

SBH broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on SBH as a result. In 71 of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.

The Moving Average Convergence Divergence (MACD) for SBH just turned positive on October 15, 2026. Looking at past instances where SBH's MACD turned positive, the stock continued to rise in 39 of 58 cases over the following month. The odds of a continued upward trend are 67%.

SBH moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SBH crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.

Following a +6.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where SBH advanced for three days, in 192 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

The Aroon Indicator entered an Uptrend today. In 133 of 196 cases where SBH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 19 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. SBH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 41 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.967) is normal, around the industry mean (2.289). P/E Ratio (9.247) is within average values for comparable stocks, (17.578). Projected Growth (PEG Ratio) (0.756) is also within normal values, averaging (1.159). Dividend Yield (0.000) settles around the average of (0.100) among similar stocks. P/S Ratio (0.430) is also within normal values, averaging (1.057).

The Tickeron Profit vs. Risk Rating rating for this company is 81 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SBH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.

Notable companies

The most notable companies in this group are Ulta Beauty (NASDAQ:ULTA), Best Buy Company (NYSE:BBY), Tractor Supply Co (NASDAQ:TSCO), Five Below (NASDAQ:FIVE), GameStop Corp (NYSE:GME), Bath & Body Works (NYSE:BBWI), RH (NYSE:RH), 1-800-FLOWERS.COM (NASDAQ:FLWS).

Industry description

The specialty stores sector includes companies dedicated to the sale of retail products focused on a single product category, such as clothing, carpet, books, or office supplies. A specialty store could face intense competition from big-box departmental chains, and therefore offering an adequate collection of the product type it specializes in is key in maintaining/growing its market.

Market Cap

The average market capitalization across the Specialty Stores Industry is 4.7B. The market cap for tickers in the group ranges from 3.1K to 50.98B. ANCTF holds the highest valuation in this group at 50.98B. The lowest valued company is SIMPQ at 3.1K.

High and low price notable news

The average weekly price growth across all stocks in the Specialty Stores Industry was 3%. For the same Industry, the average monthly price growth was 10%, and the average quarterly price growth was 16%. CHPT experienced the highest price growth at 25%, while NAAS experienced the biggest fall at -33%.

Volume

The average weekly volume growth across all stocks in the Specialty Stores Industry was -28%. For the same stocks of the Industry, the average monthly volume growth was -1% and the average quarterly volume growth was -28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 57
Price Growth Rating: 52
SMR Rating: 62
Profit Risk Rating: 87
Seasonality Score: 2 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a distributer of cosmetics, hair care and skin care goods and styling appliances

Industry SpecialtyStores

Industry
Specialty Stores
Address
3001 Colorado Boulevard
Phone
+1 800 777-5706
Employees
27000
Web
https://www.sallybeautyholdings.com
Interact to see
Advertisement
AtlasClear Holdings (ATCH) shares fell roughly 25.5% over the last 30 days, declining from $0.1881 on October 2 to $0.1401 on October 30. The pullback extended a longer downtrend that has kept the stock trading well below the $1.00 NYSE American minimum, keeping continued listing-compliance risk in focus.
XRPN fell -9.70% in early regular-session trading on Tuesday, sliding from Monday's $10.41 close to $9.40. The decline follows a November 9 SEC prospectus disclosing a committed equity facility with Cantor to sell up to 5.2 million new Class A shares at 97% of the volume-weighted average price, implying up to roughly 16.7% potential dilution.
NVDA fell -2.10% to $216.66 during regular trading, down from a prior close of $221.30. Primary catalyst: hotter-than-expected September CPI data reignited Fed rate-hike fears, raising borrowing costs for AI infrastructure buildouts.
AMD is riding record data-center momentum, with third-quarter data-center revenue up 97% year over year, while INTC faces supply constraints and weak PC guidance that triggered a sharp single-day sell-off. Relative performance has diverged sharply in 2026: AMD shares have more than doubled at their peak, whereas Intel's rally stalled after a 29% post-earnings decline.
NVDA dropped from Friday's close of $186.64 to $174.06 intraday, down -6.74%, during regular market hours. The slide followed CEO Jensen Huang's admission of an extramarital affair and the board's independent investigation, announced November 8, after reports he was targeted by a suspected Chinese intelligence operative.